Internal Medicine, Endocrinology, Diabetes, & Metabolism · Saint Peters, MO
NPI
1376644484
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
201 BJC Saint Peters Dr Ste 100
Saint Peters, MO, 63376
Phone (636) 916-7235
Groups this clinician bills Medicare through
Medicare paid, 2024
$205K
11,033 services
Medicare patients, 2024
518
Average age 72
Drug cost, 2024
$5.2M
12,812 prescriptions
Company payments, 2025
$622
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stanley Mathew was code J0897 (injection, denosumab, 1 mg), 3,720 times for 34 patients. In total Stanley Mathew billed 11,033 services in 18 codes, and Medicare paid $205K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,720 | 34 | $20.46 | $76K |
| 99214 Office E&M - Established | Office | 561 | 389 | $81.73 | $46K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 459 | 343 | $12.14 | $5,573 |
| 95251 Test - Miscellaneous | Office | 166 | 107 | $24.88 | $4,131 |
| 99232 Hospital E&M - Subsequent | Facility | 136 | 51 | $56.19 | $7,642 |
| 96372 Injection Administration | Office | 93 | 39 | $9.49 | $883 |
| 99215 Office E&M - Established | Office | 44 | 40 | $116.62 | $5,131 |
| 83036 Blood Count | Office | 42 | 34 | $9.52 | $400 |
| 99222 Hospital E&M - Initial | Facility | 39 | 39 | $88.96 | $3,469 |
| 99231 Hospital E&M - Subsequent | Facility | 30 | 16 | $36.53 | $1,096 |
| 99213 Office E&M - Established | Office | 30 | 29 | $49.65 | $1,489 |
| 99205 Office E&M - New | Office | 14 | 14 | $169.22 | $2,369 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $125.85 | $1,384 |
By year: 2022 $162K for 6,948 services; 2023 $207K for 12,483 services; 2024 $205K for 11,033 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 42 | 34 | $9.52 | $400 |
Medicare prescription drug claims, 2024
In 2024, the drug Stanley Mathew prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,107 prescriptions and refills. In total Stanley Mathew wrote 12,812 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,107 | 3,071 | 309 | $9,972 |
| Levothyroxine Sodium Generic | 1,055 | 2,979 | 281 | $9,853 |
| Ozempic Semaglutide | 988 | 1,645 | 214 | $1.6M |
| Metformin Hcl Er Metformin Hcl | 830 | 2,306 | 252 | $7,759 |
| Glimepiride Generic | 522 | 1,448 | 154 | $3,860 |
| Ezetimibe Generic | 491 | 1,388 | 137 | $7,495 |
| Pioglitazone Hcl Generic | 439 | 1,220 | 120 | $5,103 |
| Jardiance Empagliflozin | 415 | 833 | 98 | $490K |
| Glipizide Generic | 408 | 1,173 | 132 | $3,210 |
| Mounjaro Tirzepatide | 357 | 509 | 84 | $546K |
| Farxiga Dapagliflozin Propanediol | 351 | 606 | 68 | $335K |
| Lisinopril Generic | 340 | 993 | 102 | $1,504 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 338 | 842 | 116 | $42K |
| Rosuvastatin Calcium Generic | 293 | 831 | 89 | $3,716 |
| Trulicity Dulaglutide | 257 | 402 | 74 | $389K |
Brand drugs: 5,569 claims; generic drugs: 6,615 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stanley Mathew $622 ($622 in general payments such as food, travel and fees) from 14 companies. The largest payer was Amgen Inc. with $184.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 4 | $184 |
| Sequel Med Tech, LLC | 1 | $149 |
| Novo Nordisk Inc NVO | 4 | $77.77 |
| Corcept Therapeutics CORT | 1 | $23.94 |
| Radius Health, Inc. | 1 | $23.76 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $23.23 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $20.51 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $19.21 |
| IBSA Pharma Inc. | 1 | $18.85 |
| Dexcom, Inc. DXCM | 1 | $17.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.